CHANDANHEALTHCARE / Q3-FY26 / claim-ledger

Audit the questions that mattered.

Chandan Healthcare · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ3-FY26 · 2025-12-31Back to quarter ↗

Questions audited

12

Answered directly

75%

Numeric claims

5

Consistency

mixed

Question ledger

What was answered, and how?

Priu Jane · Growth X Infinity

direct

Capex required per franchisee for diagnostic centers

for franchisee we don't need to invest anything. ... we are planning to invest nearly 100 cr in 3 years

Priu Jane · Growth X Infinity

direct

Differentiators vs competitors like Dr. Lal

our main business belongs to our comprehensive centers ... we give all type of facilities under one roof

Priu Jane · Growth X Infinity

partial

Sustainability of EBITDA margins

definitely ITA margin will improve ... it is affected by our code basically graduity ... one-time expense

Priu Jane · Growth X Infinity

direct

Revenue mix target between B2C, B2B, B2G

our aim is to keep all these three at a equal level 33 33 33

Priu Jane · Growth X Infinity

direct

EBITDA margin bifurcation by segment

B2C we have nearly if the center is matured then we get EVITA 45 plus ... B2G between 30 to 40% ... B2B it is nearly 35%

Priu Jane · Growth X Infinity

evasive

Expectation of >30% topline growth next year

This is much less what we are going to give it is much less ... It will be much much higher.

Taher Hyderabad Wala · Group Buy Fund

direct

Explanation of exceptional loss of 2.2 CR

because of provisioning of employee graduity cost ... revision in wages as per new labor cost ... one time provision

Taher Hyderabad Wala · Group Buy Fund

direct

Number of labs opened and plans for Q4

up to quarter 4 we will be present in 13 states ... in this year we have already started six comprehensive centers ... 18 labs we have started

Taher Hyderabad Wala · Group Buy Fund

partial

Revenue mix between diagnostic and pharmacy

the ratio ... it is 6040 60 and in the diagnostic

Abiji Jane · AJ Capital

direct

Employee cost increase to 18% of revenue

it is because of organic expansion ... we had started 18 labs ... employee cost will definitely increase ... as soon as we will start getting the business it will come down.

Abiji Jane · AJ Capital

direct

Sustainability of 35-40% B2C EBITDA margins

if it is B2C business then it is 35 to 40 ... we expect around 30 to 35% EIA everywhere ... it is sustainable

Kushi Jane · Nan Capital

evasive

Timeline for EBITDA margins to reach 30-32%

with every quarter you will see the change ... by the end of upward change you will see.